Trihexifenidilo [Inn-Spanish] en es it fr

Trihexifenidilo [Inn-Spanish] Brand names, Trihexifenidilo [Inn-Spanish] Analogs

Trihexifenidilo [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Trihexifenidilo [Inn-Spanish] Chemical_Formula


Trihexifenidilo [Inn-Spanish] RX_link

Trihexifenidilo [Inn-Spanish] fda sheet

Trihexifenidilo_[Inn-Spanish] FDA

Trihexifenidilo [Inn-Spanish] msds (material safety sheet)

Trihexifenidilo [Inn-Spanish] Synthesis Reference

No information avaliable

Trihexifenidilo [Inn-Spanish] Molecular Weight

301.466 g/mol

Trihexifenidilo [Inn-Spanish] Melting Point

258.5 oC

Trihexifenidilo [Inn-Spanish] H2O Solubility

No information avaliable

Trihexifenidilo [Inn-Spanish] State


Trihexifenidilo [Inn-Spanish] LogP


Trihexifenidilo [Inn-Spanish] Dosage Forms

Tablet; Liquid (oral)

Trihexifenidilo [Inn-Spanish] Indication

Indicated for the treatment of parkinson's disease and extrapyramidal reactions caused by drugs.

Trihexifenidilo [Inn-Spanish] Pharmacology

Trihexyphenidyl is an anticholinergic used in the symptomatic treatment of all etiologic groups of parkinsonism and drug induced extrapyramidal reactions (except tardive dyskinesia). Trihexyphenidyl possesses both anticholinergic and antihistaminic effects, although only the former has been established as therapeutically significant in the management of parkinsonism.

Trihexifenidilo [Inn-Spanish] Absorption

Trihexyphenidyl is rapidly absorbed from the gastrointestinal tract.

Trihexifenidilo [Inn-Spanish] side effects and Toxicity

No information avaliable

Trihexifenidilo [Inn-Spanish] Patient Information

No information avaliable

Trihexifenidilo [Inn-Spanish] Organisms Affected

Humans and other mammals